|
|
|
Insider
Information: |
Quigley Jill M. |
Relationship: |
|
City: |
Philadelphia |
State: |
PA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
383,754 |
|
Indirect Shares
|
3,608 |
|
|
Direct
Value |
$411,647 |
|
|
Indirect Value
|
$2,529 |
|
|
Total
Shares |
387,362 |
|
|
Total
Value |
$414,176 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Passage Bio, Inc. |
PASG |
Chief Operating Officer |
2021-12-08 |
368,754 |
2021-12-08 |
3,608 |
Premium* |
|
Terns Pharmaceuticals, Inc. |
TERN |
|
2024-09-09 |
15,000 |
2023-11-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TERN |
Terns Pharmaceuticals, In... |
Sr. Advisor & Strategy Officer |
|
2023-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
0 |
- |
|
TERN |
Terns Pharmaceuticals, In... |
Sr. Advisor & Strategy Officer |
|
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
30,000 |
0 |
- |
|
TERN |
Terns Pharmaceuticals, In... |
|
|
2024-07-16 |
4 |
OE |
$1.82 |
$728 |
D/D |
400 |
30,400 |
0 |
- |
|
TERN |
Terns Pharmaceuticals, In... |
|
|
2024-07-16 |
4 |
AS |
$10.00 |
$4,000 |
D/D |
(400) |
30,000 |
0 |
% |
|
PASG |
Passage Bio, Inc. |
Chief Operating Officer |
|
2021-12-08 |
4 |
OE |
$0.23 |
$16,554 |
D/D |
71,975 |
368,754 |
0 |
- |
|
PASG |
Passage Bio, Inc. |
Chief Operating Officer |
|
2020-03-03 |
4 |
B |
$18.00 |
$18,000 |
I/I |
1,000 |
1,000 |
1.99 |
- |
|
TERN |
Terns Pharmaceuticals, In... |
|
|
2024-07-15 |
4 |
OE |
$1.82 |
$26,144 |
D/D |
14,365 |
44,365 |
0 |
- |
|
PASG |
Passage Bio, Inc. |
Chief Operating Officer |
|
2020-03-03 |
4 |
B |
$18.00 |
$27,000 |
D/D |
1,500 |
311,494 |
2.74 |
- |
|
TERN |
Terns Pharmaceuticals, In... |
|
|
2024-09-09 |
4 |
OE |
$1.82 |
$31,368 |
D/D |
17,235 |
32,235 |
0 |
- |
|
PASG |
Passage Bio, Inc. |
Chief Operating Officer |
|
2021-01-20 |
4 |
AS |
$30.01 |
$39,011 |
D/D |
(1,300) |
295,284 |
0 |
- |
|
TERN |
Terns Pharmaceuticals, In... |
|
|
2024-08-01 |
4 |
AS |
$7.68 |
$47,148 |
D/D |
(6,143) |
23,857 |
0 |
% |
|
TERN |
Terns Pharmaceuticals, In... |
|
|
2024-08-02 |
4 |
AS |
$7.50 |
$66,432 |
D/D |
(8,857) |
15,000 |
0 |
% |
|
TERN |
Terns Pharmaceuticals, In... |
|
|
2024-07-15 |
4 |
AS |
$10.00 |
$143,660 |
D/D |
(14,365) |
30,000 |
0 |
% |
|
TERN |
Terns Pharmaceuticals, In... |
|
|
2024-09-09 |
4 |
AS |
$10.00 |
$172,350 |
D/D |
(17,235) |
15,000 |
0 |
% |
|
PASG |
Passage Bio, Inc. |
Chief Operating Officer |
|
2021-01-14 |
4 |
S |
$30.10 |
$490,570 |
D/D |
(16,298) |
296,584 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|